Skip to main content
SpringerLink
Log in

Residual Tumor Volume, Not Percent Cytoreduction, Matters for Surgery of Neuroendocrine Liver Metastasis

  • Hepatobiliary Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Gudmundsdottir H, Habermann EB, Vierkant RA, et al. Survival and symptomatic relief after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: long-term follow-up evaluation of more than 500 patients. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13372-z.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Sarmiento JM, Heywood G, Rubin J, et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003;197(1):29–37.

    Article  PubMed  Google Scholar 

  3. Graff-Baker AN, Sauer DA, Pommier SJ, et al. Expanded criteria for carcinoid liver debulking: maintaining survival and increasing the number of eligible patients. Surgery. 2014;156(6):1369–76 (discussion 1376–7).

    Article  PubMed  Google Scholar 

  4. Maxwell JE, Sherman SK, O’Dorisio TM, et al. Liver-directed surgery of neuroendocrine metastases: what is the optimal strategy? Surgery. 2016;159(1):320–33.

    Article  PubMed  Google Scholar 

  5. Morgan RE, Pommier SJ, Pommier RF. Expanded criteria for debulking of liver metastasis also apply to pancreatic neuroendocrine tumors. Surgery. 2018;163(1):218–25.

    Article  PubMed  Google Scholar 

  6. Kasai Y, Hirose K, Corvera CU, et al. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis. J Surg Oncol. 2020;121(2):330–6.

    Article  PubMed  Google Scholar 

  7. Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of 177 Lu-Dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376(2):125–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) 2022. https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf.

  9. Strosberg J, Kunz PL, Hendifar A, et al. Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with. Eur J Nucl Med Mol Imaging. 2020;47(10):2372–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ohshima S. Volume analyzer SYNAPSE VINCENT for liver analysis. J Hepatobiliary Pancreat Sci. 2014;21(4):235–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    Yosuke Kasai MD, PhD, Akitada Yogo MD, PhD, Kazuyuki Nagai MD, PhD, Toshihiko Masui MD, PhD & Etsuro Hatano MD, PhD

  2. Department of Surgery, University of California San Francisco, San Francisco, CA, USA

    Yosuke Kasai MD, PhD, Eric K. Nakakura MD, PhD & Akitada Yogo MD, PhD

  3. Department of Surgery, Kurashiki Central Hospital, Okayama, Japan

    Toshihiko Masui MD, PhD

Authors
  1. Yosuke Kasai MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric K. Nakakura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akitada Yogo MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuyuki Nagai MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshihiko Masui MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Etsuro Hatano MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yosuke Kasai MD, PhD.

Ethics declarations

Disclosure

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kasai, Y., Nakakura, E.K., Yogo, A. et al. Residual Tumor Volume, Not Percent Cytoreduction, Matters for Surgery of Neuroendocrine Liver Metastasis. Ann Surg Oncol 30, 5457–5458 (2023). https://doi.org/10.1245/s10434-023-13834-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-13834-4

Search

Navigation